Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Shockwave Medical launches new IVL catheter for challenging lesions in Europe
The balloon-free catheter, which already had a successful in the United States, has been associated with positive outcomes and the ability to reach certain lesions more accurately than balloon-based IVL platforms.
FDA clears Apple Watch algorithm for detecting hypertension
The FDA’s decision arrived just days after Apple announced the new feature. "This tool empowers patients and clinicians to work together, putting prevention at the center of care," one cardiologist told Cardiovascular Business.
Update: FDA confirms recalls for defibrillation leads after nearly 400 injuries
Safety concerns with certain Boston Scientific leads has resulted in multiple Class I recalls, the FDA has announced. The agency first shared a warning about this issue in August.
Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately
The FDA has categorized this as a Class I recall. If patients update their phone or watch apps as needed, they can continue to use these devices like normal.
Cardiologist sues hospital after he was allegedly let go for sharing safety concerns
The veteran interventional cardiologist claims he was pushed out after repeatedly asking for more coverage from cardiothoracic surgeons in addition to other improvements. The hospital, meanwhile, described the lawsuit as a “collection of false allegations."

Obesity to overtake smoking as No. 1 cause of preventable cancers in women

A report published by charity organization Cancer Research U.K. suggests obesity is on track to eclipse smoking as the greatest cause of preventable cancer in British women—something experts say could happen by 2043, the Guardian has reported.

TCT.18: Anticipated OAC-ALONE results ‘underpowered, inconclusive’

OAC-ALONE, the first randomized trial to test the efficacy of oral anticoagulation (OAC) alone against combined OAC and a single antiplatelet agent (APT) in patients with atrial fibrillation and stable coronary artery disease, was unable to establish noninferiority of OACs to dual therapy, according to data presented at the 30th annual TCT conference in San Diego.

Taller height identified as risk factor for development of varicose veins

Height—and the genes that influence it—are important predictors for the development of varicose veins, according to a study out of Stanford University.

TCT.18: BIONYX finds novel zotarolimus-eluting stent noninferior to Orsiro

Resolute Onyx, a polymer-coated zotarolimus-eluting stent, has been proven safe and effective in an all-comer population of more than 2,000 heart patients, according to late-breaking results of the BIONYX trial.

TCT.18: TAVR outcomes not swayed by valve type, anesthesia approach

SAN DIEGO — General and local anesthesia are comparably safe and effective during transcatheter aortic valve replacement (TAVR) procedures, according to the first randomized trial to compare the two approaches.

TCT.18: COAPT draws superlatives, raises questions about replicating MitraClip’s benefits

Compared to heart failure patients with severe secondary mitral regurgitation who were treated with guideline-directed medical therapy alone, those randomized to a MitraClip procedure plus optimal medical therapy demonstrated relative reductions of 47 percent for heart failure hospitalizations and 38 percent for mortality at two years of follow-up.

TCT.18: Ultra-thin Orsiro stent outperforms Xience at 2 years of follow-up

SAN DIEGO — The ultra-thin Orsiro drug-eluting stent (DES) maintained superior outcomes at two years of follow-up in a head-to-head trial against Abbott’s Xience stent, according to results presented this weekend at Transcatheter Cardiovascular Therapeutics 2018 and published online in the Journal of the American College of Cardiology.

OHCA protocol with angiography, therapeutic cooling slashes mortality rates

A strict protocol mandating coronary angiography and therapeutic hypothermia contributed to “startling” improvements in survival rates for out-of-hospital cardiac arrest (OHCA), researchers reported in JACC: Cardiovascular Interventions.

Clinical

Shockwave Medical launches new IVL catheter for challenging lesions in Europe

FDA clears Apple Watch algorithm for detecting hypertension

Update: FDA confirms recalls for defibrillation leads after nearly 400 injuries

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately

Cardiologist sues hospital after he was allegedly let go for sharing safety concerns